2020-05
2020-05-14Advances in Virus Research: Environmental Virology and Virus Ecology
| ISBN | 01281441573 |
| ISBN13 | 9780128144152 |
| PRICE | US$171.00 特別価格で提供します |
| Author | Malmstrom, Carolyn M. |
| Edition | Edit.1; / Vol.101 |
| Pages | 339 |
| Publisher | Academic Press |
| 発刊 | 2019 |
| Categories | MEDIMEDICAL / Infectious Diseases / Virology |
Environmental Virology, Volume 101, the latest in the Advances in Virus Research series, contains new, informative updates on the topic. First published in 1953, this series covers a diverse range of in-depth reviews, providing a valuable overview of the current field of virology. Updates to this release include sections on the host landscape and vector behavior, key determinants of plant virus evolution and emergence, plant virome analysis using spatial metagenomics, host range evolution in generalist viruses, the influence of environment, water-mediated spread and transmission of viruses, viruses transmitted by means other than insect vectors, and more.
Contains contributions from leading authorities in the field of virologyInforms and updates on all the latest developments in the fieldFeatures a diverse range of virology topics, including discussions of host landscape and vector behavior and viruses transmitted by means other than insect vectors
2020-05-14Infectious Diseases
| ISBN | 1536164011 |
| ISBN13 | 9781536164015 |
| PRICE | US$230.00 特別価格で提供します |
| Author | Georges, Philippe |
| Edition | 1 |
| Pages | 296 |
| Publisher | Nova Science Pub Inc |
| 発刊 | 2019 |
| Categories | MEDIMEDICAL / Infectious Diseases / Microbiology |
An infectious disease threat is unique because of the transmissibility of diseases and the mobility of human populations. Infectious disease threats in recent years—such as Zika and Ebola outbreaks—have heightened the United States’ attention to future potential threats, and raised questions about the nation’s preparedness and response capabilities. Chapter 1 describes funding HHS has made available to awardees through its key preparedness and capacity-building programs—ELC, HPP, and PHEP; and these programs’ performance measurement data on the awardees’ infectious disease preparedness capacity.
The World Health Organization (WHO) declared the Zika virus a public health emergency of international concern in February 2016. Zika virus disease can cause adverse pregnancy and neurological outcomes. Chapter 2 examines information on what is known and not known about the epidemiology of the Zika virus, and any challenges with conducting surveillance and epidemiological studies, characteristics of different diagnostic tests authorized during the outbreak, challenges test manufacturers and users faced, and the extent to which FDA and CDC followed their own communication guidance, and the strengths and limitations of available mosquito control methods, and challenges federal agencies face supporting these efforts. Chapter 3 describes the status of funds obligated and disbursed from the Zika supplemental funding appropriated to HHS and its agencies; and how selected awardees used their Zika supplemental funding, and their experiences with applying for and managing the funding. Chapter 4 examines the status of USAID and State funding for U.S. Zika response overseas, activities supported by these funds, and implementation challenges, if any, and responses to any challenges.
The 2014-2015 Ebola outbreak in West Africa caused long-term second-order impacts, including disruptions to health systems, job loss, and food insecurity. As of September 30, 2017, of the $1.6 billion that the U.S. Agency for International Development (USAID) had obligated for the Ebola outbreak. Chapter 5 examines obligations for USAID’s Ebola recovery projects, the status of USAID’s implementation of these projects, and USAID’s evaluation of Ebola recovery efforts. On August 1, 2018, the World Health Organization (WHO) reported a new Ebola outbreak in eastern DRC, about a week after declaring that a separate outbreak had ended in western DRC as reported in chapter 6.
Between September 2018 and May 2019, the number of African swine fever (ASF) outbreaks has rapidly increased, most notably in China, triggering economic losses in affected pork-producing countries as discussed in chapter 7.
As reported in chapter 9, Tuberculosis (TB) remains a major, and evolving, health challenge in many parts of the world and a priority for the U.S. Congress and international community.
Congress has long taken an interest in infectious disease prevention and control. According to chapter 10, the measles, mumps, and rubella (MMR) vaccine is 97% effective in preventing infection and related deaths, and routine MMR vaccination is recommended for all children.
2020-05-13Ebola Virus Disease (EVD): Outbreaks, Control and Prevention Strategies
| ISBN | 1536162914 |
| ISBN13 | 9781536162912 |
| PRICE | US$82.00 特別価格で提供します |
| Author | Verreau, Hilaire |
| Edition | 1 |
| Pages | 130 |
| Publisher | Nova Science Pub Inc |
| 発刊 | 2019 |
| Categories | MEDIMEDICAL / Infectious Diseases / Virology |
To mitigate the spread of the rare and deadly disease Ebola, Ebola Virus Disease (EVD): Outbreaks, Control and Prevention Strategies begins with the proposition of a mathematical model with vital dynamics and two preventive measures: quarantine and isolation. Humanitarian issues in Ebola prevention and control are explored, as well as the cultural practices and social norms during outbreaks. Additionally, some innovative approaches in the humanitarian response to prevention and control are discussed. The authors expose the dilemma Ebola poses to within the healthcare system, where healthcare providers are caught between the over-arching quest for self-preservation from a highly virulent disease and the professional demand of prioritising the interests of the patients over self. In conclusion, the authors describe successfully developed drug candidates from their laboratory for the treatment Ebola using EBOV protein structure, such as VP24, VP35, VP40, nucleoprotein, and glycoprotein.
2020-05-13Field’s Virology: Emerging Viruses
| ISBN | 1975112547 |
| ISBN13 | 9781975112547 |
| PRICE | US$139.99 特別価格で提供します |
| Author | Howley, Peter M., M.D./ Knipe, David M., Ph.D. Whelan, Sean P. J., Ph.D./ Cohen, Jeffrey I., M.D. Enquist, Lynn, Ph.D. |
| Edition | 7 |
| Pages | 826 |
| Publisher | Lippincott Williams & Wilkins |
| 発刊 | 2020 |
| Categories | MEDIMEDICAL / Infectious Diseases / Virology |
Bundled with the eBook, which will be updated regularly as new information about each virus is available, including content on coronavirus and COVID-19, this text serves as the authoritative, up-to-date reference book for virologists, infectious disease specialists, microbiologists, and physicians, as well as medical students pursuing a career in infectious diseases
Bundled with the eBook, which will be updated regularly as new information about each virus is available, including content on coronavirus and COVID-19, this text serves as the authoritative, up-to-date reference book for virologists, infectious disease specialists, microbiologists, and physicians, as well as medical students pursuing a career in infectious diseases
2020-05-11新型コロナウィルスによる影響について
新型コロナウィルス感染症に罹患された皆様に、心よりお見舞い申し上げます。
また、診療にあたられている全ての医療従事者の皆様に深く感謝致します。
弊社の提供する書籍にも一部遅延が生じる可能性がございますが、
何卒ご容赦頂けますようお願い申し上げます。
感染により発病された方々の一日も早い快復をお祈り申し上げます。